We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Helena Laboratories

Helena Laboratories is a clinical laboratory instrument and reagent manufacturer with a product range comprising elec... read more Featured Products: More products

Download Mobile App




Simplified Microchip Electrophoresis Rapidly Separates Urinary Proteins

By LabMedica International staff writers
Posted on 27 Mar 2014
A urine protein test is to detect the presence of protein in a person's urine, while in healthy individuals, there is only very low concentration of protein in urine, but in renal patients, the concentration of urine protein will increase considerably.

Urine protein test has been widely used in clinics, but to determine the type of proteinuria is usually difficult due to technical limitations. More...
A rapid and simple method to separate and determine urine proteins by a microchip electrophoresis (ME) system has been developed which can be completed rapidly.

Scientists at the Affiliated Hospital of Nantong University (Jiangsu Province, China) developed quick and straightforward method to separate urine proteins with ME. By testing different experimental conditions, the optimal parameters were established and the duration of the analytical run takes less than four minutes. They compared ME and conventional agarose gel electrophoresis (AGE) and by analyzing 248 urine samples.

The chip electrophoresis apparatus consisted of an optical module, a control module, and a detection module (Shanghai Institute of Microsystem and Information Technology; China). The 214 nm UV light was obtained by a hologram grating and focused the separation channel to detect the presence of protein. The light absorbed by a sample was gathered by a photomultiplier tube (Hamamatsu; Beijing, China) and converted to electric signals, which were then processed by a filtering and amplifying circuit and input to a computer.

The patient group contained 178 urine samples, of which no protein peak was detected for 7 samples, 60 were selective proteinuria with primary protein of albumin, 105 were nonselective proteinuria with various molecular weight proteins, and 6 were overflow proteinuria. The same results were obtained by conventional AGE (Helena; Beaumont, TX, USA) as the ME.

The authors concluded that the assay was rapid, simple, and convenient, with electrophoretic time only four minutes with good reproducibility. The electrophoresis apparatus and detection system were cheap and microfluidic chip could be repeated. The newly established ME provided a useful clinical tool with broad potential applications for the diagnosis, treatment, and prognosis of renal and related diseases. The study was published in the March 2014 issue of the Journal of Clinical Laboratory Analysis.

Affiliated Hospital of Nantong University
Shanghai Institute of Microsystem and Information Technology
Helena 

Related Links:

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Manual Pipetting Aid
Pipette Controllers macro
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.